SEE is based on currently published medical literature; the program does not represent opinions or recommendations of the ASA. The SEE Editorial Board and Task Force members, all of whom are ASA members, work together to create a program that presents relevant topics from more than 40 leading international medical journals—translating emerging anesthesia knowledge for your daily practice.
Included in issue 33B:
- A novel molecule-encapsulating drug, calabadion 2, that reverses rocuronium and vecuronium as well as cisatracurium and the anesthesia induction drugs etomidate and ketamine
- Safety of continuing chest compressions during defibrillation when wearing gloves
- Use of the back-up, head-elevated (BUHE) position to improve intubation success
- Noninvasive ventilation (NIV) for the management of postoperative hypoxic respiratory failure and use of a helmet rather than a mask to improve the effectiveness of NIV
- And much more!
More information about SEE